Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,714 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase 2 Sensitivity and Selectivity Study of High-Dose 5-Aminolevulinic Acid in Adult Patients Undergoing Resection of a Newly Diagnosed or Recurrent Glioblastoma.
Cozzens JW, Lokaitis BC, Delfino K, Hoeft A, Moore BE, Fifer AS, Amin DV, Espinosa JA, Jones BA, Acakpo-Satchivi L. Cozzens JW, et al. Among authors: moore be. Oper Neurosurg (Hagerstown). 2024 Nov 11. doi: 10.1227/ons.0000000000001417. Online ahead of print. Oper Neurosurg (Hagerstown). 2024. PMID: 39526779
Intensive Care Unit Readmissions in a Level I Trauma Center.
Moore B, Daniels KJ, Martinez B, Sexton KW, Kalkwarf KJ, Roberts M, Bowman SM, Jensen HK. Moore B, et al. J Surg Res. 2024 Oct 25:S0022-4804(24)00638-3. doi: 10.1016/j.jss.2024.09.074. Online ahead of print. J Surg Res. 2024. PMID: 39490383
Identification of cytokine release syndrome and indicators of severity in retrospective databases among patients receiving immunotherapy.
Huntington SF, Lin D, Lafeuille MH, Thompson-Leduc P, Shah A, Kim N, Hester L, Tardif-Samson A, Moore B, Fowler J, Marshall A, Zhang X, Gifkins D, Wu B. Huntington SF, et al. Among authors: moore b. Pharmacol Res Perspect. 2024 Dec;12(6):e70024. doi: 10.1002/prp2.70024. Pharmacol Res Perspect. 2024. PMID: 39487576 Free PMC article.
Comparison of Time to Next Treatment or Death Between Front-Line Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Bortezomib, Lenalidomide, and Dexamethasone (VRd) Among Transplant-Ineligible Patients With Multiple Myeloma.
Hansen DK, Gautam S, Lafeuille MH, Rossi C, Moore B, Tardif-Samson A, Thompson-Leduc P, Fu AZ, Cortoos A, Kaila S, Fonseca R. Hansen DK, et al. Among authors: moore b. Cancer Med. 2024 Nov;13(21):e70308. doi: 10.1002/cam4.70308. Cancer Med. 2024. PMID: 39486091 Free PMC article.
3,714 results